Cynosure Group’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-9,527
Closed -$300K 521
2025
Q3
$300K Hold
9,527
0.03% 344
2025
Q2
$405K Buy
9,527
+2,912
+44% +$121K 0.05% 284
2025
Q1
$295K Buy
6,615
+1,629
+33% +$87.7K 0.04% 356
2024
Q4
$274K Sell
4,986
-2,937
-37% -$149K 0.04% 347
2024
Q3
$335K Buy
+7,923
New +$377K 0.05% 351

Other funds holding VCEL

Cynosure Group's VCEL Position: Q4 2025 in Review

Cynosure Group sold out of Vericel Corp (VCEL) in Q4 2025, closing a stake of 9,527 shares — an estimated $300K sold.

Cynosure Group first reported a position in VCEL in Q3 2024 and held it in 5 quarters. The position peaked at $405K in Q2 2025. 273 funds tracked by Wall St. Rank hold VCEL as of Q4 2025.

  • Cynosure Group reported no remaining Vericel Corp position as of Q4 2025 after selling out during the quarter.
  • Cynosure Group sold 9,527 Vericel Corp shares in Q4 2025, an estimated $300K.
  • Cynosure Group first reported a position in Vericel Corp in Q3 2024 and held it in 5 quarters.
  • Cynosure Group's Vericel Corp position peaked at $405K in Q2 2025.
  • 273 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2025.

Based on Cynosure Group's 13F filing for Q4 2025, filed 17 Feb 2026.